Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma

Clinical trial NCT03960866 · COMPLETED

Trial details

NCT number: NCT03960866
Sponsor: Ocuphire Pharma, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Open Angle Glaucoma Ocular Hypertension

Start date: 2019-05-28
Primary completion: 2019-09-11
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.